(Q38186068)

30 August 2017

title

Future directions for anti-biofilm therapeutics targeting Candida (English)

1 reference

30 August 2017

0 references

Jeniel E Nett

1

1 reference

30 August 2017

publication date

9 February 2014

1 reference

Expert Review of Anti-infective Therapy

30 August 2017

published in

1 reference

30 August 2017

volume

12

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

375-382

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

30 August 2017

1 reference

Biofilms and device-associated infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Production of extracellular matrix by Candida albicans biofilms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Candida infections of medical devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Epidemiology of invasive candidiasis: a persistent public health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Resistance of Candida albicans biofilms to antifungal agents in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Development and characterization of an in vivo central venous catheter Candida albicans biofilm model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Antifungal resistance of candidal biofilms formed on denture acrylic in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Putative role of beta-1,3 glucans in Candida albicans biofilm resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Fungal biofilm resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

A contact-activated kinase signals Candida albicans invasive growth and biofilm development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

A small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Candida albicans biofilms produce antifungal-tolerant persister cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Role of matrix β-1,3 glucan in antifungal resistance of non-albicans Candida biofilms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Role for cell density in antifungal drug resistance in Candida albicans biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Penetration of Candida biofilms by antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

In vitro method to study antifungal perfusion in Candida biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Hsp90 governs dispersion and drug resistance of fungal biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Amphotericin B lipid complex is efficacious in the treatment of Candida albicans biofilms using a model of catheter-associated Candida biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

21 January 2018

Antifungal lock therapy

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Potentiation of azole antifungals by 2-adamantanamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Carbohydrate Derived Fulvic Acid: An in vitro Investigation of a Novel Membrane Active Antiseptic Agent Against Candida albicans Biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Characterization of plant-derived saponin natural products against Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

In vitro activity of caspofungin against Candida albicans biofilms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Injectable in situ cross-linking hydrogels for local antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Comparative in vitro efficacies of various catheter lock solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Prostaglandin production during growth of Candida albicans biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

The role of diclofenac sodium in the dimorphic transition in Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Dispersion as an important step in the Candida albicans biofilm developmental cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Biofilm matrix regulation by Candida albicans Zap1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Endocytosis-mediated vacuolar accumulation of the human ApoE apolipoprotein-derived ApoEdpL-W antimicrobial peptide contributes to its antifungal activity in Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Effect of usnic acid on Candida orthopsilosis and C. parapsilosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Anticandidal efficacy of cinnamon oil against planktonic and biofilm cultures of Candida parapsilosis and Candida orthopsilosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

The effects of tea polyphenols on Candida albicans: inhibition of biofilm formation and proteasome inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Antimicrobial activity of Croton cajucara Benth linalool-rich essential oil on artificial biofilms and planktonic microorganisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Effects of fresh garlic extract on Candida albicans biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Investigating the biological properties of carbohydrate derived fulvic acid (CHD-FA) as a potential novel therapy for the management of oral biofilm infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Development of a high-throughput Candida albicans biofilm chip

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Development and validation of an in vivo Candida albicans biofilm denture model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Development of a contemporary animal model of Candida albicans-associated denture stomatitis using a novel intraoral denture system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

A murine model for catheter-associated candiduria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

Pharmacology of Systemic Antifungal Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.885838

10.1586/14787210.2014.885838

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference